ABPRX
Price
$76.83
Change
-$0.14 (-0.18%)
Updated
Apr 17 closing price
Net Assets
23.47B
VIGRX
Price
$181.21
Change
+$0.19 (+0.10%)
Updated
Apr 17 closing price
Net Assets
260.76B
Ad is loading...

ABPRX vs VIGRX

Header iconABPRX vs VIGRX Comparison
Open Charts ABPRX vs VIGRXBanner chart's image
AB Large Cap Growth R
Price$76.83
Change-$0.14 (-0.18%)
VolumeN/A
Net Assets23.47B
Vanguard Growth Index Investor
Price$181.21
Change+$0.19 (+0.10%)
VolumeN/A
Net Assets260.76B
ABPRX vs VIGRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ABPRX vs. VIGRX commentary
Apr 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABPRX is a Buy and VIGRX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 261B vs. ABPRX (23.5B). VIGRX pays higher dividends than ABPRX: VIGRX (0.39) vs ABPRX (0.00). ABPRX was incepted earlier than VIGRX: ABPRX (21 years) vs VIGRX (32 years). ABPRX (1.23) is less costly to investors than VIGRX (0.17). ABPRX is a more actively managed with annual turnover of: 30.00 vs. VIGRX (5.00). ABPRX has a lower initial minimum investment than VIGRX: ABPRX (0) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 6.13 vs. ABPRX (-6.33). VIGRX return over 5 years is better than : 99.42 vs. ABPRX (43.65).
ABPRXVIGRXABPRX / VIGRX
Total Expense Ratio1.220.17718%
Annual Report Gross Expense Ratio1.230.17724%
Fund Existence21 years32 years-
Gain YTD-12.285-14.23686%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets23.5B261B9%
Annual Yield % from dividends0.000.39-
Returns for 1 year-6.336.13-103%
Returns for 3 years12.8630.4642%
Returns for 5 years43.6599.4244%
Returns for 10 years97.66224.1844%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RCKT6.330.18
+2.93%
Rocket Pharmaceuticals
OVV33.820.72
+2.18%
Ovintiv
USAC25.220.31
+1.24%
USA Compression Partners LP
UNB31.340.35
+1.13%
Union Bankshares
VVOS2.100.02
+0.96%
Vivos Therapeutics